title: Cutaneous metastatic Crohn's disease responsive to infliximab.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Petrolati
authors.forename: Nadia
authors.initials: N
authors.lastname: Altavilla
authors.forename: Rosanna
authors.initials: R
authors.lastname: Cipolla
authors.forename: Pompeo
authors.initials: P
authors.lastname: Fenderico
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Forlini
authors.forename: Silvia
authors.initials: S
authors.lastname: Nasoni
authors.forename: Zaccaria
authors.initials: Z
authors.lastname: Rossi
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D000069285:Infliximab; D012883:Skin Ulcer / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab